HIG in $278m healthcare take-private

The mid-market firm will augment its healthcare portfolio with Allion, a provider of pharmaceuticals and disease management services to HIV/AIDS and chronically ill patients.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this